Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Novespace | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Cardiovascular events remain the main cause of death of the industrialized world (Global status report on noncommunicable diseases 2010. Geneva, World Health Organization, 2011). Arterial hypertension, hyperlipoproteinemia, smoking, diabetes and family history represent the main cardiovascular risk factors. Arteriosclerosis leads to coronary heart disease, cerebrovascular insufficiency and peripheral vascular diseases that reflect in myocardial infarction and stroke.
The main objective of this experiment is to investigate the differential effect of microgravity on central aortic blood pressure.
The main criterion is the central aortic pressure (measured in mmHg). The hypothesis is that microgravity leads to an increased central aortic pressure.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Microgravity | Other | effect of microgravity on central aortic blood pressure. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| central aortic pressure (measured in mmHg). | Other | Blood pressure will only be measured during the 0g (microgravity) phase. Seven 5 ml blood sample will be drawn in the aircraft: before the first parabola (1) and after each block of 5 parabola (6). On ground after flight, a 9th 5 ml blood sample will be drawn and then the mobil-o-graph, the SOMNOtouch NIBP and the intravenous cannula will be removed. |
| Measure | Description | Time Frame |
|---|---|---|
| central aortic pressure | effect of microgravity on central aortic blood pressure (measured in mmHg). | baseline |
Not provided
Not provided
Inclusion Criteria:
Subjects will be staff member of the team or of other teams participating in the parabolic flight campaign.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Pierre DP Denise, PhD | Contact | 02.31.06.81.32 | +33 | pierre.denise@unicaen.fr |
| Cathy GC Gaillard | Contact | 02 31 06 53 49 | +33 | gaillard-c@chu-caen.fr |
| Name | Affiliation | Role |
|---|---|---|
| Pierre DP Denise, PhD | University Hospital, Caen | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Caen CHU | Recruiting | Caen | 14000 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|